Balter Invenomic is trading at 17.94 as of the 22nd of March 2025; that is 0.66 percent down since the beginning of the trading day. The fund's open price was 18.06. Balter Invenomic has about a 20 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 22nd of December 2024 and ending today, the 22nd of March 2025. Click here to learn more.
The fund invests primarily in both long and short positions in equity securities principally traded in United States markets. Invenomic Fund is traded on NASDAQ Exchange in the United States. More on Balter Invenomic Fund
Balter Invenomic Fund [BIVIX] is traded in USA and was established 22nd of March 2025. Balter Invenomic is listed under Invenomic category by Fama And French industry classification. The fund is listed under Long-Short Equity category and is part of Invenomic family. This fund currently has accumulated 1.4 B in assets under management (AUM) with no minimum investment requirementsBalter Invenomic is currently producing year-to-date (YTD) return of 3.41% with the current yeild of 0.04%, while the total return for the last 3 years was 7.69%.
Check Balter Invenomic Probability Of Bankruptcy
Instrument Allocation
Top Balter Invenomic Fund Mutual Fund Constituents
Other Information on Investing in Balter Mutual Fund
Balter Invenomic financial ratios help investors to determine whether Balter Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Balter with respect to the benefits of owning Balter Invenomic security.